This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Actuate Therapeutics Inc.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Andrew Mazar: Innovator in Malignant Lymphoproliferative Disorders
Introduction
Andrew Mazar is a notable inventor based in Fort Worth, TX (US). He has made significant contributions to the field of medicine, particularly in the treatment of malignant lymphoproliferative disorders. With a total of 2 patents, Mazar's work focuses on innovative therapeutic methods that aim to improve patient outcomes.
Latest Patents
Mazar's latest patents include methods of treating malignant lymphoproliferative disorders. These methods involve administering an effective amount of a GSK-3β inhibitor, such as 9-ING-41. Additionally, he has developed methods that combine the GSK-3β inhibitor with other therapeutic agents to enhance treatment efficacy.
Career Highlights
Throughout his career, Andrew Mazar has worked with various organizations, including Actuate Therapeutics Inc. and Wilson Therapeutics Ab. His experience in these companies has allowed him to refine his expertise in developing innovative treatment methods.
Collaborations
Mazar has collaborated with notable professionals in his field, including Francis Giles and Robert J. Ternansky. These collaborations have contributed to the advancement of his research and the development of his patents.
Conclusion
Andrew Mazar's contributions to the treatment of malignant lymphoproliferative disorders highlight his innovative spirit and dedication to improving patient care. His patents and collaborations reflect a commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile